{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Miami",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "91175",
      "recalling_firm": "Beckman Coulter, Inc.",
      "address_1": "11800 Sw 147th Ave",
      "address_2": "N/A",
      "postal_code": "33196-2500",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US and Canada, Brazil, Korea, Mexico, Puerto Rico, Taiwan",
      "recall_number": "Z-0777-2023",
      "product_description": "BECKMAN COULTER IRISpec CA/CB/CC control, REF 900-7211, For in vitro diagnostic  use only.",
      "product_quantity": "3657 units",
      "reason_for_recall": "Beckman Coulter has become aware of an increase in customer complaints generated for intermittent IRISpec CB glucose control false positive results when used in conjunction with iChemVelocity Urine Chemistry Strips PN 800-7212",
      "recall_initiation_date": "20221118",
      "center_classification_date": "20230103",
      "report_date": "20230111",
      "code_info": "UDI/DI 10837461002611, Lot 565-21: 11-30-2022"
    }
  ]
}